The International Journal of Tuberculosis and Lung Disease

TB in the elderly in industrialised countries [Editorial]
pp. 1157-1159(3)
Author: Davies, Peter D. O.

Ziehl-Neelsen staining: strong red on weak blue, or weak red under strong blue? [Counterpoint]
pp. 1160-1161(2)
Authors: Angra, P.; Becx-Bleumink, M.; Gilpin, C.; Joloba, M.; Jost, K.; Kam, K.M.; Kim, S.J.; Lumb, R.; Mitarai, S.; Ramsay, A.; Ridderhof, J.; Rieder, H.L.; Selvakumar, N.; van Beers, S.; van Cleeff, M.; Van Deun, A.; Vincent, V.

The assessment of new anti-tuberculosis drugs for a paediatric indication [Counterpoint]
pp. 1162-1165(4)
Author: Donald, P.R.

Nucleic acid amplification tests for the diagnosis of tuberculous lymphadenitis: a systematic review [Review Article]
pp. 1166-1176(11)
Authors: Daley, P.; Thomas, S.; Pai, M.

Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers
pp. 1177-1182(6)
Authors: Cobanoglu, N.; Ozcelik, U.; Kalyoncu, U.; Ozen, S.; Kiraz, S.; Gurcan, N.; Kaplan, M.; Dogru, D.; Yalcin, E.; Pekcan, S.; Kose, M.; Topaloglu, R.; Besbas, N.; Bakkaloglu, A.; Kiper, N.

Tuberculosis infection in drug users: interferon-gamma release assay performance
pp. 1183-1189(7)
Authors: Grimes, C.Z.; Hwang, L-Y.; Williams, M.L.; Austin, C.M.; Graviss, E.A.

Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals
pp. 1190-1195(6)
Authors: Jones, S.; de Gijsel, D.; Wallach, F.R.; Gurtman, A.C.; Shi, Q.; Sacks, H.

Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in Spain
pp. 1196-1202(7)
Authors: Diez, M.; Diaz, A.; Bleda, M.J.; Aldamiz, M.; Camafort, M.; Camino, X.; Cepeda, C.; Costa, A.; Ferrero, O.; Geijo, P.; Iribarren, J.A.; Moreno, S.; Moreno, M.E.; Labarga, P.; Pinilla, J.; Portu, J.; Pulido, F.; Rosa, C.; Santamaria, J.M.; Telenti, M.; Trapiella, L.; Trastoy, M.; Viciana, P.

Tolerability of anti-tuberculosis treatment and HIV serostatus
pp. 1203-1209(7)
Authors: Lanternier, F.; Dalban, C.; Perez, L.; Bricaire, F.; Costagliola, D.; Caumes, E.

Social support and incentives programme for patients with tuberculosis: experience from the Russian Federation
pp. 1210-1215(6)
Authors: Jakubowiak, W.M.; Bogorodskaya, E.M.; Borisov, S.E.; Danilova, I.D.; Lomakina, O.B.; Kourbatova, E.V.

Tuberculosis and multidrug resistance in Zambian prisons, 2000-2001
pp. 1216-1220(5)
Authors: Habeenzu, C.; Mitarai, S.; Lubasi, D.; Mudenda, V.; Kantenga, T.; Mwansa, J.; Maslow, J.N.

Anti-tuberculosis drug resistance among new and previously treated pulmonary tuberculosis patients in Cotonou, Benin
pp. 1221-1224(4)
Authors: Affolabi, D.; Adjagba, O.A.B.G.; Tanimomo-Kledjo, B.; Gninafon, M.; Anagonou, S.Y.; Portaels, F.

The decline of tuberculosis epidemics under chemotherapy: a case study in Morocco
pp. 1225-1231(7)
Authors: Dye, C.; Ottmani, S.; Laasri, L.; Bencheikh, N.

Evaluation of the Arkansas method of urine testing for isoniazid in South Africa
pp. 1232-1236(5)
Authors: Hanifa, Y.; Mngadi, K.; Lewis, J.; Fielding, K.; Churchyard, G.; Grant, A.D.

Open access World Wide Web resources on upper and lower respiratory tract infections
pp. 1237-1245(9)
Authors: Fragoulis, K.N.; Korbila, I.P.; Dimopoulos, G.; Falagas, M.E.

Results of PAL feasibility test in primary health care facilities in four regions of Bolivia
pp. 1246-1252(7)
Authors: Camacho, M.; Nogales, M.; Manjon, R.; Del Granado, M.; Pio, A.; Ottmani, S.

Validation of a new clinical scoring system for acute bronchitis
pp. 1253-1259(7)
Authors: Mwachari, C.; Nduba, V.; Nguti, R.; Park, D.R.; Sanguli, L.; Cohen, C.R.

Asthma knowledge and approach among Pakistani family physicians and the impact of an educational programme
pp. 1260-1265(6)
Authors: Haque, A.S.; Zubairi, A.B.S.; Shiraz, A.; Zuberi, F.; Karim, S.I.; Pervez, R.; Awan, S.

George Wills Comstock, 1915-2007 [In Memoriam]
pp. 1266-1266(1)
Author: Chaisson, Richard E.